Efficacy of otilonium bromide in irritable bowel syndrome: a pooled analysis

BACKGROUND: Otilonium bromide (OB) is a spasmolytic agent acting as an L-type calcium channel antagonist in intestinal and colonic smooth muscle cells (SMCs). We analyzed three independent clinical trials with homogeneous design on patients with irritable bowel syndrome (IBS). After 2 weeks receivin...

Descripción completa

Detalles Bibliográficos
Autores principales: Clavé, Pere, Tack, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305018/
https://www.ncbi.nlm.nih.gov/pubmed/28246548
http://dx.doi.org/10.1177/1756283X16681708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305018/
https://www.ncbi.nlm.nih.gov/pubmed/28246548
http://dx.doi.org/10.1177/1756283X16681708

Ejemplares similares